- 全部删除
您的购物车当前为空
CC-115 是一种双重 mTOR/DNA-PK 的抑制剂,IC50分别为 21 nM 和 13 nM,可阻断mTORC1和mTORC2信号通路。

CC-115 是一种双重 mTOR/DNA-PK 的抑制剂,IC50分别为 21 nM 和 13 nM,可阻断mTORC1和mTORC2信号通路。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 258 | In stock | |
| 5 mg | ¥ 619 | In stock | |
| 10 mg | ¥ 993 | In stock | |
| 25 mg | ¥ 1,920 | In stock | |
| 50 mg | ¥ 3,180 | In stock | |
| 100 mg | ¥ 4,560 | In stock | |
| 200 mg | ¥ 6,380 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 683 | In stock |
CC-115 相关产品
| 产品描述 | CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). |
| 靶点活性 | mTOR:21nM, DNA-PK:13 nM, PI3Kα:852 nM |
| 体外活性 | CC-115的IC50值对一系列CYP酶均>10μM,对hERG离子通道>33μM。在以10μM浓度对Cerep受体和酶面板进行单点筛选时,仅有一个靶点的抑制率超过50%(PDE3,IC50 = 0.63μM)。 |
| 体内活性 | CC-115在多个物种中展现了良好的药代动力学(PK)特征,分别在小鼠、大鼠和狗中的口服生物利用度达到53%、76%和100%。CC-115具备有利的理化性质和药代动力学属性,能有效抑制mTOR途径和肿瘤生长,并且具有良好的安全性,适合进行临床开发。 |
| 细胞实验 | Freshly isolated CLL cells are treated with different concentrations of CC-115 for 30 minutes. Subsequently, the cells are exposed to 5-Gy γ-radiation or treated with 10 µg/mL bleomycin (EMD Millipore, Billerica, MA) and incubated for 30 minutes, and cell lysates are made. (Only for Reference) |
| 别名 | CC 115 |
| 分子量 | 336.35 |
| 分子式 | C16H16N8O |
| CAS No. | 1228013-15-7 |
| Smiles | CCN1C(=O)CNc2ncc(nc12)-c1ccc(nc1C)-c1ncn[nH]1 |
| 密度 | 1.56 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 62 mg/mL (184.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容